CN109998021A - 健脾胃、抗动脉硬化、降三高、补钙养颜的面粉 - Google Patents
健脾胃、抗动脉硬化、降三高、补钙养颜的面粉 Download PDFInfo
- Publication number
- CN109998021A CN109998021A CN201810408590.XA CN201810408590A CN109998021A CN 109998021 A CN109998021 A CN 109998021A CN 201810408590 A CN201810408590 A CN 201810408590A CN 109998021 A CN109998021 A CN 109998021A
- Authority
- CN
- China
- Prior art keywords
- parts
- spleen
- semen
- stomach
- oat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000952 spleen Anatomy 0.000 title claims abstract description 45
- 210000002784 stomach Anatomy 0.000 title claims abstract description 30
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 239000011575 calcium Substances 0.000 title claims abstract description 25
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 25
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 21
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 19
- 230000003796 beauty Effects 0.000 title claims abstract description 18
- 235000013312 flour Nutrition 0.000 title claims abstract description 17
- 238000005728 strengthening Methods 0.000 title claims abstract description 17
- 201000001421 hyperglycemia Diseases 0.000 title claims abstract description 16
- 206010003210 Arteriosclerosis Diseases 0.000 title claims abstract description 14
- 208000011775 arteriosclerosis disease Diseases 0.000 title claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 72
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 52
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 52
- 244000075850 Avena orientalis Species 0.000 claims abstract description 51
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 51
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 44
- 240000008042 Zea mays Species 0.000 claims abstract description 43
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 39
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 39
- 235000005822 corn Nutrition 0.000 claims abstract description 39
- 241000233866 Fungi Species 0.000 claims abstract description 30
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 28
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 28
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 28
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 28
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 28
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 28
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 28
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 28
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 28
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 28
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 28
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 28
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 28
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 28
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 28
- 240000008669 Hedera helix Species 0.000 claims abstract description 24
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 22
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 21
- 235000019713 millet Nutrition 0.000 claims abstract description 21
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 19
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 19
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 19
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940026314 red yeast rice Drugs 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 16
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 16
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 16
- 244000268590 Euryale ferox Species 0.000 claims abstract description 15
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 15
- 240000004371 Panax ginseng Species 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 241001474374 Blennius Species 0.000 claims abstract description 12
- 210000003038 endothelium Anatomy 0.000 claims abstract description 12
- 241000238557 Decapoda Species 0.000 claims abstract description 11
- 244000088415 Raphanus sativus Species 0.000 claims abstract 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 241001251949 Xanthium sibiricum Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 78
- 206010028980 Neoplasm Diseases 0.000 abstract description 12
- 201000011510 cancer Diseases 0.000 abstract description 12
- 230000029087 digestion Effects 0.000 abstract description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 49
- 210000004369 blood Anatomy 0.000 description 41
- 239000008280 blood Substances 0.000 description 40
- 230000006870 function Effects 0.000 description 32
- 210000003491 skin Anatomy 0.000 description 30
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 24
- 235000013305 food Nutrition 0.000 description 23
- 235000012000 cholesterol Nutrition 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 22
- 239000003814 drug Substances 0.000 description 21
- 235000019197 fats Nutrition 0.000 description 19
- 239000000126 substance Substances 0.000 description 18
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 17
- 235000007686 potassium Nutrition 0.000 description 17
- 239000011591 potassium Substances 0.000 description 17
- 229910052700 potassium Inorganic materials 0.000 description 17
- 230000001603 reducing effect Effects 0.000 description 17
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 15
- 235000016709 nutrition Nutrition 0.000 description 15
- 229920001282 polysaccharide Polymers 0.000 description 15
- 239000005017 polysaccharide Substances 0.000 description 15
- 229930003935 flavonoid Natural products 0.000 description 14
- 150000002215 flavonoids Chemical class 0.000 description 14
- 235000017173 flavonoids Nutrition 0.000 description 14
- 206010012735 Diarrhoea Diseases 0.000 description 13
- 150000004676 glycans Chemical class 0.000 description 13
- 230000036541 health Effects 0.000 description 13
- 240000007594 Oryza sativa Species 0.000 description 12
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 12
- 241000220259 Raphanus Species 0.000 description 12
- 210000004204 blood vessel Anatomy 0.000 description 12
- 229960003284 iron Drugs 0.000 description 12
- 229910052742 iron Inorganic materials 0.000 description 12
- 230000035764 nutrition Effects 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- 241000219051 Fagopyrum Species 0.000 description 11
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 11
- 235000007164 Oryza sativa Nutrition 0.000 description 11
- 230000008901 benefit Effects 0.000 description 11
- 230000036772 blood pressure Effects 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 150000002632 lipids Chemical class 0.000 description 11
- 235000013372 meat Nutrition 0.000 description 11
- 235000010755 mineral Nutrition 0.000 description 11
- 239000011707 mineral Substances 0.000 description 11
- 235000009566 rice Nutrition 0.000 description 11
- 241000221377 Auricularia Species 0.000 description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 10
- 239000007789 gas Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 230000002265 prevention Effects 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 235000021307 Triticum Nutrition 0.000 description 9
- 241000209140 Triticum Species 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 229930003231 vitamin Natural products 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000001976 improved effect Effects 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 8
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 235000014786 phosphorus Nutrition 0.000 description 8
- 239000011574 phosphorus Substances 0.000 description 8
- 229910052698 phosphorus Inorganic materials 0.000 description 8
- 150000003722 vitamin derivatives Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 7
- -1 anthracene Amide Chemical class 0.000 description 7
- 230000003712 anti-aging effect Effects 0.000 description 7
- 230000001093 anti-cancer Effects 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 238000005755 formation reaction Methods 0.000 description 7
- 235000001055 magnesium Nutrition 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 229910052749 magnesium Inorganic materials 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 6
- 235000007558 Avena sp Nutrition 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 6
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 229930003944 flavone Natural products 0.000 description 6
- 235000011949 flavones Nutrition 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 239000011630 iodine Substances 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 230000004089 microcirculation Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000004224 protection Effects 0.000 description 6
- 235000005875 quercetin Nutrition 0.000 description 6
- 229960001285 quercetin Drugs 0.000 description 6
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 6
- 235000014347 soups Nutrition 0.000 description 6
- 230000002087 whitening effect Effects 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 208000010706 fatty liver disease Diseases 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 235000015424 sodium Nutrition 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 235000016804 zinc Nutrition 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 208000004930 Fatty Liver Diseases 0.000 description 4
- 206010019708 Hepatic steatosis Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 235000014103 egg white Nutrition 0.000 description 4
- 210000000969 egg white Anatomy 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 4
- 230000029142 excretion Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 150000002213 flavones Chemical class 0.000 description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 235000009973 maize Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 230000000050 nutritive effect Effects 0.000 description 4
- 230000001151 other effect Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 4
- 235000005493 rutin Nutrition 0.000 description 4
- 229960004555 rutoside Drugs 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 231100000240 steatosis hepatitis Toxicity 0.000 description 4
- 230000004206 stomach function Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000010444 Acidosis Diseases 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 3
- 208000020084 Bone disease Diseases 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229920001503 Glucan Polymers 0.000 description 3
- 206010018612 Gonorrhoea Diseases 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 206010041497 Spermatorrhoea Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000007950 acidosis Effects 0.000 description 3
- 208000026545 acidosis disease Diseases 0.000 description 3
- 230000001142 anti-diarrhea Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003471 anti-radiation Effects 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 210000001772 blood platelet Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 229940108928 copper Drugs 0.000 description 3
- 229960004397 cyclophosphamide Drugs 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229960002986 dinoprostone Drugs 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229960000304 folic acid Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- 239000011724 folic acid Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempherol Natural products C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 3
- 201000005630 leukorrhea Diseases 0.000 description 3
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- 235000019161 pantothenic acid Nutrition 0.000 description 3
- 239000011713 pantothenic acid Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010046901 vaginal discharge Diseases 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- IDUUXROOZBOOPH-QHHAFSJGSA-N 2-{[(2E)-3-(3,4-dihydroxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-hydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1NC(=O)\C=C\C1=CC=C(O)C(O)=C1 IDUUXROOZBOOPH-QHHAFSJGSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 241001552669 Adonis annua Species 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 229930190481 Avenanthramide Natural products 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000001126 Keratosis Diseases 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000294142 Vascellum Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 244000285940 beete Species 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000011222 chang cao shi Nutrition 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000003648 hair appearance Effects 0.000 description 2
- 230000003699 hair surface Effects 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 235000008777 kaempferol Nutrition 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000007708 morin Nutrition 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical class COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000605447 Anemarrhena Species 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
- 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000238367 Mya arenaria Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 241001404159 Platysmurus leucopterus Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 244000181025 Rosa gallica Species 0.000 description 1
- 235000000533 Rosa gallica Nutrition 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 229930187719 Soyasaponin Natural products 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 201000003761 Vaginal carcinoma Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002908 adrenolytic effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229930191283 anemarrhena Natural products 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Natural products C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000003840 blood vessel health Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 235000013495 cobalt Nutrition 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940124567 diuretic antihypertensive agent Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- FPVGTPBMTFTMRT-NSKUCRDLSA-L fast yellow Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 FPVGTPBMTFTMRT-NSKUCRDLSA-L 0.000 description 1
- 235000021149 fatty food Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutanoic acid Natural products NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000003700 hair damage Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000000893 inhibin Substances 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000036564 melanin content Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229930185723 monacolin Natural products 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940038580 oat bran Drugs 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000024053 secondary metabolic process Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000011031 topaz Substances 0.000 description 1
- 229910052853 topaz Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 235000021228 wine soup Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/40—Shell-fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种健脾胃、抗动脉硬化、降三高、补钙养颜的面粉,本发明以质量配比计包括:人参50~100份、燕麦50~100份、玉米50~100份、苦荞麦50~100份、葛根50~100份、黑豆50~100份、小米50~100份、白扁豆50~100份、淮山药50~100份、莲子50~100份、白茯苓50~100份、薏苡仁50~100份、芡实50~100份、陈皮50~100份、山楂50~100份、莱菔子50~100份、海带50~100份、红曲50~100份、黑木耳50~100份、鸡内金50~100份、虾米50~100份、海藻50~100份、木香50~100份、砂仁50~100份。本发明具有健脾胃助消化、抗动脉硬化、降三高、补钙养颜、防癌抗癌的效果。
Description
技术领域
本发明属于食品领域,特别涉及一种健脾胃、抗动脉硬化、降三高、补钙养颜的面粉。
背景技术
传统的面粉都是通过小麦磨成粉而成,功效单一,然而随着现代人生活水平的提高,饮食越来越好,饮食过量,影响到脾胃功能的正常运作,则又造成营养吸收不良的恶性循环;或因脾胃功能先天禀赋不足,消化功能柔弱,造成体内血脂肪过高、肥胖、动脉硬化、老人、小孩缺钙、容颜憔悴等亚健康状态。
发明内容
本发明针对背景技术中传统面粉功效单一等不足,提供一种健脾胃、抗动脉硬化、降三高、补钙养颜的面粉。
一种健脾胃、抗动脉硬化、降三高、补钙养颜的面粉,以重量配比计包括:人参50~100份、燕麦50~100份、玉米50~100份、苦荞麦50~100份、葛根50~100份、黑豆50~100份、小米50~100份、白扁豆50~100份、淮山药50~100份、莲子50~100份、白茯苓50~100份、薏苡仁50~100份、芡实50~100份、陈皮50~100份、山楂50~100份、莱菔子50~100份、海带50~100份、红曲50~100份、黑木耳50~100份、鸡内金50~100份、虾米50~100份、海藻50~100份、木香50~100份、砂仁50~100份。
在其中一个实施例中,以重量配比计包括:人参50份、燕麦50份、玉米50份、苦荞
麦50份、葛根50份、黑豆50份、小米50份、白扁豆50份、淮山药50份、莲子50份、白茯苓50份、薏苡仁50份、芡实50份、陈皮50份、山楂100份、莱菔子50份、海带100份、红曲50份、黑木耳50份、鸡内金50份、虾米50份、海藻50份、木香50份、砂仁50份。
在其中一个实施例中,以重量配比计包括:人参50份、燕麦80份、玉米80份、苦荞
麦80份、葛根80份、黑豆80份、小米80份、白扁豆80份、淮山药80份、莲子80份、白茯苓80份、薏苡仁80份、芡实80份、陈皮100份、山楂100份、莱菔子50份、海带100份、红曲50份、黑木耳50份、鸡内金50份、虾米50份、海藻50份、木香50份、砂仁50份。
本发明的优点及其有益效果
本发明人参、白扁豆、淮山药补气健脾,白茯苓、芡实、薏苡仁祛湿健脾,陈皮、木香、砂仁芳香健脾开窍,莲子、小米养胃,陈皮、莱菔子和胃,山楂、鸡内金、莱菔子帮助消化;黑豆、黑木耳、芡实、小米补肾,配合山楂、莱菔子、海带、海藻、苦荞麦、红曲、燕麦、玉米、葛根降血糖、降血脂肪、降血压、降低胆固醇,清除血管中的垃圾,疏通血管,软化血管,预防动脉硬化,抗衰老;葛根还可以护肝,玉米可以补充维生素A的不足,起明目的作用,玉米、燕麦、陈皮、山楂、海带、苦荞麦等还具有润肠通便减肥的功效,薏苡仁还具有补肺美白皮肤的功效,黑豆、海带乌发。上述食物都具有防癌抗癌的功能,组合达到健脾胃、助消化、抗动脉硬化、降三高、补钙通便养颜、防癌抗癌的效果,本发明为养生精品,为健康护航的必备食品。
具体实施方式
为使本发明的上述目的、特征和优点能够更加明显易懂,下面对本发明的具体实施方式做详细的说明。在下面的描述中阐述了很多具体细节以便于充分理解本发明。但是本发明能够以很多不同于在此描述的其它方式来实施,本领域技术人员可以在不违背本发明内涵的情况下做类似改进,因此本发明不受下面公开的具体实施的限制。
实施例1
一种健脾胃、抗动脉硬化、降三高、补钙养颜的面粉,以重量配比计包括:以重量配比计包括:人参50份、燕麦50份、玉米50份、苦荞麦50份、葛根50份、黑豆50份、小米50份、白扁豆50份、淮山药50份、莲子50份、白茯苓50份、薏苡仁50份、芡实50份、陈皮50份、山楂100份、莱菔子50份、海带100份、红曲50份、黑木耳50份、鸡内金50份、虾米50份、海藻50份、木香50份、砂仁50份。
本发明的制作方法:准备人参50份、燕麦50份、玉米50份、苦荞麦50份、葛根50份、黑豆50份、小米50份、白扁豆50份、淮山药50份、莲子50份、白茯苓50份、薏苡仁50份、芡实50份、陈皮50份、山楂100份、莱菔子50份、海带100份、红曲50份、黑木耳50份、鸡内金50份、虾米50份、海藻50份、木香50份、砂仁50份;然后将上述原料混合在一起,再将其粉碎成粉,得到本发明的成品。
实施例2
一种健脾胃、抗动脉硬化、降三高、补钙养颜的面粉,以重量配比计包括:人参50份、
燕麦80份、玉米80份、苦荞麦80份、葛根80份、黑豆80份、小米80份、白扁豆80份、淮山药80份、莲子80份、白茯苓80份、薏苡仁80份、芡实80份、陈皮100份、山楂100份、莱菔子50份、海带100份、红曲50份、黑木耳50份、鸡内金50份、虾米50份、海藻50份、木香50份、砂仁50份。
本发明的制作方法:准备人参50份、燕麦80份、玉米80份、苦荞麦80份、葛根80
份、黑豆80份、小米80份、白扁豆80份、淮山药80份、莲子80份、白茯苓80份、薏苡仁80份、芡实80份、陈皮100份、山楂100份、莱菔子50份、海带100份、红曲50份、黑木耳50份、鸡内金50份、虾米50份、海藻50份、木香50份、砂仁50份;然后将上述原料混合在一起,再将其粉碎成粉,得到本发明的成品。
本发明的优点及其有益效果:
本发明人参、白扁豆、淮山药补气健脾,白茯苓、芡实、薏苡仁祛湿健脾,陈皮、木香、砂仁芳香健脾开窍,莲子、小米养胃,陈皮、莱菔子和胃,山楂、鸡内金、莱菔子帮助消化;黑豆、黑木耳、芡实、小米补肾,配合山楂、莱菔子、海带、海藻、苦荞麦、红曲、燕麦、玉米、葛根降血糖、降血脂肪、降血压、降低胆固醇,清除血管中的垃圾,疏通血管,软化血管,预防动脉硬化,抗衰老;葛根还可以护肝,玉米可以补充维生素A的不足,起明目的作用,玉米、燕麦、陈皮、山楂、海带、苦荞麦等还具有润肠通便减肥的功效,薏苡仁还具有补肺美白皮肤的功效,黑豆、海带乌发。上述食物都具有防癌抗癌的功能,组合达到健脾胃、助消化、抗动脉硬化、降三高、补钙通便养颜、防癌抗癌的效果,本发明为养生精品,为健康护航的必备食品。
1、本发明包括燕麦;据中国医学科学院卫生研究所综合分析,中国裸燕麦含粗蛋白质达15.6%,脂肪8.5%,还有淀粉释放热量以及磷、铁、钙等元素,与其它8种粮食相比,均名列前茅。燕麦中水溶性膳食纤维分别是小麦和玉米的4.7倍和7.7倍。燕麦中的B族维生素、尼克酸、叶酸、泛酸都比较丰富,特别是维生素E,每100g燕麦粉中高达15mg。此外燕麦粉中还含有谷类食粮中均缺少的皂甙(人参的主要成分)。蛋白质的氨基酸组成比较全面,人体必需的8种氨基酸含量均居首位,尤其是含赖氨酸高达0.68g。燕麦米煮的粥富含镁和维生素B1,也含有磷、钾、铁、泛酸、铜和纤维,可以降低胆固醇,对脂肪肝、糖尿病、便秘等也有辅助疗效。未经烹制的燕麦麸富含镁、维生素B1、磷、钾,也含有铁、锌、叶酸、泛酸和铜。燕麦片可以改善血液循环,促进伤口愈合。
(1)燕麦的药用价值;燕麦具有降低血压、降低胆固醇、防治大肠癌、防治心脏疾病的医疗价值和保健作用,已被古今中外医学界所公认。
2011年7月至10月,历时121天的时间,北京大学医学部专家组在内蒙古包头市展开了一场全胚芽裸燕麦米调理干预Ⅱ型糖尿病患者的科研活动,来自全国15个省市的404位糖尿病患者,有96.5%的糖友餐前餐后血糖、糖化血红蛋白、脂肪肝以及胰岛细胞的修复等身体各项指标均得以改善。全世界首次用一种粮食去干预糖尿病,并取得丰硕成果。对于因肝、肾病变,糖尿病,脂肪肝等引起的继发性高脂血症也有同样明显的疗效。长期食用燕麦米,有利于糖尿病和肥胖病的控制。
燕麦中的膳食纤维具有降低甘油三脂的低密度脂肪蛋白,促使胆固醇排泄,防治糖尿病,有利于减少糖尿病的血管并发症的发生;可通便导泄,对于习惯性便秘患者有很好的帮助;燕麦片属低热食品,食后易引起饱感,长期食用具有减肥功效。此外,燕麦中含有丰富的维生素B1、B2、E、叶酸等,可以改善血液循环、缓解生活工作带来的压力;含有的钙、磷、铁、锌、锰等矿物质也有预防骨质疏松、促进伤口愈合、防止贫血的功效。
(2)燕麦具有保湿润肤、美白祛斑、抗皱抗氧化、滋润护发的美容作用;燕麦除了有天然的保健功能外,还具有很高的美容价值。人们很早就已经懂得利用燕麦来治疗皮肤干燥和痊痒。据考古专家考察,古代埃及后妃们就有燕麦水洗浴的习惯。
燕麦中含有燕麦蛋白、燕麦肽、燕麦β葡聚糖、燕麦油等成分,具有抗氧化功效、增加肌肤活性、延缓肌肤衰老、美白保湿、减少皱纹色斑、抗过敏、等功效。在美国、日本、韩国、加拿大、法国等国家称燕麦为“家庭医生”、“植物黄金”、“天然美容师”。燕麦米煮粥的汤汁,可以直接敷在脸上,或者浸泡压缩面膜后敷脸。
燕麦β-葡聚糖是一种线性无分支粘多糖,通过β-(1-3)和β-(1-4)糖苷键把β-D-吡喃葡萄糖单位连接起来,形成一种高分子的聚合物,因其含有大量的亲水基团,可以吸收水分或锁住皮肤角质层水分,燕麦β-葡聚糖具有非常好的保湿功效,可以促进成纤维细胞合成胶原蛋白,促进伤口愈合,具有良好的皮肤修复功能。此外,燕麦β-葡聚糖特有的理化性状,能赋予皮肤光滑如丝绸般的质感,给人愉悦、舒适和高雅的感觉。
蛋白质是燕麦最主要的成分之一,蛋白质经酶解可得到小分子的肽和氨基酸,这一类分子中都含有亲水基团,可以吸收水分或锁住皮肤角质层水分,具有非常好的保湿功效。大分子量的燕麦蛋白可以在较低浓度下成膜,起到包埋或隔离小分子物质的作用,可快速传递活性成分或定时释放,改善发质和干涩皮肤。蛋白质、多肽和氨基酸还是组织和细胞生长发育必须的营养物资,在化妆品中添加这些物质,还可以滋润肌肤、营养细胞、促进皮肤组织健康的生长发育。
燕麦富含优质油脂,主要由不饱和脂肪酸组成,燕麦油脂质成分和水合特性能在油中乳化大量的水分,可以作为表皮层水合保湿剂的有效载体;燕麦油还可以在皮肤表面形成一层油膜,起到长效保湿的作用;燕麦精油中的不饱和脂肪酸成分,能够软化皮肤,滋润养颜,给予舒适的肤感。
皮肤的颜色主要决定于表皮内黑色素含量的多少,人体中的黑色素是由黑色素细胞产生的,在黑素细胞内,酪氨酸在酪氨酸酶等的催化下经过一系列生化反应生成黑色素。在黑色素的形成反应中,酪氨酸酶是主要的限速酶,抑制酪氨酸酶的活性即可抑制黑色素的生成,同时,抗氧化剂能够抑制黑色素生成的生化反应,因而也可以减少黑色素的形成。燕麦提取物中含有大量的能够抑制酪氨酸酶活性的生物活性成分,其抑制能力与化妆品常用的美白剂—熊果苷接近,但燕麦提取物的成本要比熊果苷低得多。此外,燕麦中含有大量的抗氧化成分,这些物质可以有效地抑制黑色素形成过程中氧化还原反应的进行,减少黑色素的形成,淡化色斑,保持白皙靓丽的皮肤。
燕麦中含有大量的抗氧化物质,酚酸类有:咖啡酸、阿魏酸、香豆酸、安息香酸、香草酸、芥子酸、原儿茶酸、水杨酸、没食子酸、丁香酸等;类黄酮化合物包括:5,7,4’-三羟基黄酮、3’,4’,5,7-四羟基黄酮、4’,5,7-三羟基-3’、5’-二甲氧基黄酮;还有维生素E、燕麦蒽酰胺等等,这些物质都可以有效地清除自由基,减少自由基对皮肤细胞的伤害,减少皱纹的出现,淡化色斑,保持皮肤富有弹性和光泽。
燕麦蒽酰胺,又称燕麦生物碱,是燕麦特有的物质,燕麦蒽酰胺不仅具有清除自由基抗皱的功效,还具有抗刺激的特性,尤其当紫外线照射对皮肤产生不利作用时,它具有有效去除肤表泛红的功能,对过敏性皮肤具有优异的护理作用。
头发有一定的防御和保持体温的功能,但对于人类来说,更重要的是头发可以作为人的第二性征,头发的疏密、质量和外观修饰特征,很大程度上影响着人的容貌和精神气质,因此,洗护发产品在日化和美容行业占有很大的比重。
头发的基本成分是角质蛋白,燕麦蛋白质可在头发表面形成保护膜,润滑头发表层,减少摩擦力,从而减少因梳理等引起的头发损伤。燕麦蛋白质类还可以提供营养,促进头发的健康生长。
头发含水量的变化对头发质量和表观性状影响很大,如果头发吸水过多,会引起头发内蛋白质间氢键的破坏,从而使原有的发型及体积发生变化,甚至产生梳理困难等现象;如果头发失水过多,头发过度干燥,头发静电增加,导致乱发、飘发等现象。燕麦蛋白质在头发表面形成保护膜可以保持头发内水分的相对稳定,从而保持头发的光滑、柔顺和亮泽。
2、本发明包括玉米;玉米含有膳食纤维,具有刺激胃肠蠕动、加速粪便排泄的作用,可防治便秘、肠炎、肠癌等;玉米所富含的天然维生素E有保护皮肤、促进血液循环、降低胆固醇、防止皮肤病变、延缓衰老的功效,同时还能减轻动脉硬化和脑功能衰退;玉米含有的黄体素、玉米黄质,可以有效地预防眼睛老化;玉米还有利尿降压、止血止泻、助消化的作用;玉米可降低人体血液胆固醇含量,预防高血压和冠心病的发生,中美洲印第安人不易患高血压与他们主要食用玉米有关;玉米胚芽所含的营养物质,有增强人体新陈代谢、调整神经系统功能,使皮肤细嫩光滑,抑制、延缓皱纹的产生。
玉米的代谢能为14.06MJ/kg,高者可达15.06MJ/kg,是谷实类中最高的。这主要由于玉米中粗纤维很少,仅2%;而无氮浸出物高达72%,且消化率可达90%;另一方面,玉米的粗脂肪含量高,在3.5%至4.5%之间。玉米为一年生禾本科植物,又名苞谷、棒子、六谷等。据研究测定,每100g玉米含热量106kcal,纤维素2.9g,蛋白质4.0g,脂肪1.2g,碳水化合物22.8g,另含矿物质元素和维生素等。玉米中含有的粗纤维,比精米、精面高4~10倍。玉米中还含有大量镁,镁可加强肠壁蠕动,促进机体废物的排泄。玉米上述的成份与功能,对于减肥非常有利。玉米成熟时的花穗玉米须,有利尿作用,也对减肥有利。玉米可煮汤代茶饮,也可粉碎后制作成玉米粉、玉米糕饼等。膨化后的玉米花体积很大,食后可消除肥胖人的饥饿感,但食后含热量很低,也是减肥的代用品之一。
3、本发明包括苦荞麦;苦荞麦具有降血糖、降血脂、治疗心律失调、治疗心绞痛、治疗心肌梗塞、扩张血管、抗菌、抗病毒、抗氧化、抗癌防癌、清楚自由基、治疗骨病和骨质疏松症的作用。
(1)苦荞麦对内分泌系统的作用;苦荞麦具有降血糖作用:苦荞生物类黄酮能够促进胰岛β细胞的恢复,降低血糖和血清胆固醇,改善糖耐量对抗肾上腺素的升血糖作用,同时它还能够抑制醛糖还原酶,因此可以治疗糖尿病及其并发症;苦荞麦具有降血脂作用:苦荞生物类黄酮中所富含的槲皮素等能降低甘油三酯,总胆固醇,减少动脉粥样硬化指数。
(2)苦荞麦具有对心肌的作用:可用于治疗心律失调,心绞痛,心肌梗塞等症;苦荞麦还具有对血管的作用:苦荞生物类黄酮所富含的芦丁等具有扩张血管的作用,槲皮素、桑色素等能够改善血管平滑肌的收缩、舒张功能。
(3)苦荞麦具有抗菌、抗病毒作用;据研究证实,苦荞生物类黄酮所富含的槲皮素、桑色素、莰非醇有抑菌和抗病毒作用。临床应用该黄酮,对各种原因引起的溃疡有祛腐生肌,消炎镇痛的奇特疗效。
(4)苦荞麦具有抗氧化作用;抑制油脂自动氧化中3-OH、5-OH、4-基和2,3位的双键起主导作用。抑制油脂氧化的能力槲皮素>桑色素>芦丁。
(5)苦荞麦具有抗癌、防癌作用;苦荞生物类黄酮所富含的槲皮素等黄酮类化合物主要通过三个途径达到抗癌、防癌作用,即抗自由基作用,直接抑制癌细胞生长,抗致癌因子。鞑靼荞生物类黄酮所含的五羚基黄酮是抗癌、防癌、治癌的优选药物。
(6)苦荞麦具有清除自由基作用;自由基(free radical)是引起癌症,衰老,心脑血管退变性疾病的罪恶之源。因为苦荞类黄酮物质易氧化,才使其具有清除能力,它们具有五个羟基,可以充足地作为供氢体,使自由基还原,从而起到清除自由基的目的,达到防衰、抗癌,抗心脑血管病的目的。
(7)苦荞麦对骨组织的作用;苦荞生物类黄酮可用于治疗骨病和骨质疏松等症,其作用机理在于:其一,它既可抑制前列腺素E2(PGE2)的胶原蛋白合成增加,又能抑制PGE2的胶原蛋白合成减少,即抑制{BH}一脯氨酸进入可消化的胶原蛋白和非胶原蛋白中,并在低浓度PGE2时主要作用于非胶原蛋白的合成,高浓度PGE2时主要作用于胶原蛋白合成。因此可以用于治疗骨病;其二,它能提高甲状腺对雌激素的敏感性,使甲状腺C细胞分泌降钙素的作用加强,最终抑制骨再吸收而治疗骨质疏松;其三,它能抑制饮食中缺钙和维生素D引起的骨密度和骨钙含量的降低。
(8)苦荞麦对免疫系统的作用;苦荞生物类黄酮能明显有效地增加机体的非特异免疫功能和体液免疫功能。
(9)苦荞麦具有护肝作用;苦荞生物类黄酮对急慢性肝炎、肝硬化,脂肪肝以及因半乳糖胺和CCL4等引起的中毒性肝损伤均有一定的疗效。研究表明,苦荞生物类黄酮对CCL4所致肝脏丙二醛(MDA肝脂质过氧化中产物)含量的增高有明显的抑制作用。可减轻肝细胞中的转氨酶等可溶性酶因从细胞中漏出而活性升高;苦荞生物类黄酮的护肝机制最终在于它的抗氧化和抗自由基的作用。
(10)苦荞麦具有抗紫外线作用;苦荞生物类黄酮所富含的槲皮素等黄酮类化合物是一种光屏蔽物,具有吸收紫外线的功能。苦荞麦可保护抗坏血酸等生物活性物质免除氧化,保持了它们的活性,是一种极好的抗氧化剂,其螯合作用和基因表达出减少脂肪氧化变性的功能作用明显。尤其是该黄酮对皮肤的保健作用,年青化及血管的保健,抗炎症作用特别显著,故有人称之为“皮肤营养素”。
人们又从苦荞麦中制备出苦荞麦蛋白复合物(Tartary buckwheat proteincomplex,TBPC),并研究了其营养成分和抗衰老作用,结果如下:在苦荞蛋白复合物中蛋白质含量为63.4%,脂肪12.7%,碳水化合物10.2%, 灰分3.5%,粗纤维0.4%,水分9.8%。同时还含有多种氨基酸,其人体必需氨基酸和非必需氨基酸占到全部氨基酸的45.8%左右,并含一定的脂肪酸和微量元素等物质。
苦荞麦中富含生物类黄铜;主要成份是芦丁,又名维生素P。其主要功效是:软化血管、改善微循环、清热解毒、活血化瘀、拔毒生肌、有降血糖、尿糖、血脂、益气提神、加强胰岛素外周作用。
苦荞麦中富含微量元素和矿物质;含有多种有益人体健康的无机元素钙、磷、铁、铜、锌和微量元素硒等,镁的含量是小麦面粉的11倍以上,铁元素是其它主粮的2 ~5倍,锌为1.5倍以上,锰为1.4倍以上,钾为小麦的2倍,大米的2.3倍,黄玉米面的1.5倍。镁、钾的高含量大大增强了苦荞粉的营养保健功能。
苦荞麦富含淀粉;苦荞麦淀粉为支链淀粉,含大量凝胶黏液,加热后呈弱碱性,对胃酸过多有抑制作用。对病灶可起到缓解和屏障保护作用。
苦荞麦富含维生素;苦荞中含有丰富的维生素。维生素B2的含量是玉米粉和大米的2~10倍。维生素PP有降低人体血脂和胆固醇的作用,是治疗高血压、心血管病的重要辅助药物;尤其是对老年患者具有特别疗效,能降低微血管脆性和渗透性,恢复其弹性。对防止脑溢血、维持眼循环,保护和增进视力有效。维生素E中r生育酚含量较高,对防止氧化和治疗不育症有效,并有促进细胞再生、防止衰老作用。
苦荞麦中富含维生素;也称膳食纤维,含量达到1.6%,是普通米面的8倍之多,具有整肠通便,清除体内毒素的良好功效,是人体消化系统的清道夫。
苦荞麦中油酸和亚油酸含量极高,而亚油酸是人体最重要的脂肪酸,体内不能合成。对幼儿有促进生长发育作用。对成年人可防止冠心病。同时因含有抑制皮肤生成黑色素的物质(2,4二羟基顺式肉桂酸),有预防雀斑及老年斑的作用。
苦荞麦富含蛋白质;含有19种天然氨基酸,总含量高达11.82%。特别含有一般植物如小麦、稻米所缺少的赖氨酸,富含精氨酸和组氨酸。并且苦荞蛋白有近1/3为清理蛋白,可清理体内毒素和异物,而且,苦荞蛋白由于富含精氨酸,可以防止体脂增加。
苦荞麦还含有其它粮食作物不具备的叶绿素。
苦荞麦富含生物类黄酮、叶绿素、粗蛋白以及多种微量元素。黑苦荞茶所含芦丁可软化血管、具有降血脂、降血糖、降血压,减肥败毒,清理人体垃圾,激活胰岛素分泌等功效。富含蛋白质矿物元素和人体必须的9种脂肪酸、亚油酸等生物活性物质,可健脾开胃,通便润肠。长期饮用有益身体健康。
4、本发明包括红曲;具有降血压、降低胆固醇和甘油三酯、活血化瘀、健脾消食的作用。红曲主治:饮食积滞,脘腹胀满,赤白下痢,产后恶露不尽,跌打损伤。
(1)降血压;红曲的二级代谢产物——γ氨基丁酸为脑神经传导的促进物质,根据许多实验证实,红曲的功效与作用有利于降低血压。
(2)降低胆固醇和甘油三酯;日本专家从红曲菌培养液中分离出一种与他汀类药相似的特殊成分“红曲菌素”,能抑制甲基戊二酰辅酶A的活性(后者恰是决定胆固醇合成的关键酶),进而降低胆固醇。实验表明,红曲的功效与作用还可以降低血液中的甘油三酯与低密度脂蛋白胆固醇,提升高密度脂蛋白胆固醇,使血管不易堵塞。
(3)活血化瘀、健脾消食;治产后恶露不净,瘀滞腹痛,食积饱胀,赤白下痢,跌打损伤。 《饮膳正要》:健脾,益气,温中。 《本草衍义补遗》:活血消食,健脾暖胃,赤白痢下水谷。《纲目》:治女人血气痛及产后恶血不尽,擂酒饮之良。 《本草备要》:入营而破血,燥胃消食,活血和血。治赤白下痢,跌打损伤。 《医林纂要》:解生冷物毒。
5、本发明包括葛根。
(1)提高肝细胞的再生能力,恢复正常肝脏机能,促进胆汁分泌,防止脂肪在肝脏堆积。 (2)促进新陈代谢,加强肝脏解毒功能,防止酒精对肝脏的损伤。
(3)对高血脂形成的冠状动脉硬化,通过改善心肌缺血状态,防治冠心病、心绞痛、心肌梗塞等心血管疾病。
(4)对高血脂形成的脑动脉硬化,通过改善脑缺血状态,防治脑梗塞、偏瘫、血管性痴呆等脑血管疾病。
(5)强化肝胆细胞自身免疫功能,抵抗病毒入侵。
6、本发明包括黑豆;黑豆为肾之谷,可以祛风除热、调中下气、解毒利尿,降低血中胆固醇,还可驻颜、明目、乌发,使皮肤白嫩等。
(1)提高免疫力;黑豆含植物性蛋白质,有“植物肉”的美称。人体如果缺少蛋白质,会出现免疫力下降、容易疲劳的症状。吃黑豆补蛋白质,可避免胆固醇升高的问题。
(2)让人头脑聪明;黑豆富含大豆卵磷脂,它是大脑的重要组成成分之一。多吃黑豆有助于预防老年痴呆症。此外,黑豆卵磷脂中的甾醇,可增加神经机能和活力。同时卵磷脂可以乳化、分解油脂,加速新陈代谢。促进脂肪降解,保护心脏,预防脂肪肝等疾病的发生。并且提高脑力活动,消除大脑疲劳,提高学习和工作效率。
(3)强健器官;黑豆卵磷脂能促进溶性维生素的吸收,强健人体的组织器官。另外,它可以降低胆固醇,改善脂质代谢,预防和治疗冠状动脉硬化。
(4)提高效率;黑豆中的蛋白质可以增加大脑皮层的兴奋和抑制功能,提高学习和工作效率,还有助于缓解沮丧、抑郁的情绪。
(5)美白护肤;黑豆大豆异黄酮,这种植物雌激素能改善皮肤衰老,还能缓解更年期综合征。此外,日本研究人员发现,黑豆中含有的亚油酸可以有效阻止皮肤细胞中的黑色素的合成。
(6)预防癌症;黑豆含有蛋白酶抑制素,美国纽约大学研究员实验发现,它可以抑制多种癌症,对乳腺癌的抑制效果最为明显。
(7)阻止氧化;黑豆中的大豆皂苷能清除体内自由基,具有抗氧化的作用。它还能抑制肿瘤细胞的生长,增强人体免疫机能。
(8)降低血脂;黑豆中的植物胆固醇有降低血液胆固醇的作用。它在肠道内与胆固醇竞争,减少胆固醇吸收。在降低高血脂症患者中的“坏胆固醇”的同时,不影响血液中的“好胆固醇”,有很好的降脂效果。
(9)预防耳聋;补充铁可以扩张微血管,软化红血球,保证耳部的血液供应,可以有效防止听力减退。黑豆中的铁和锌的含量较其他食物高很多,对预防老年人耳聋有一定作用。
(10)辅助降压;美国科学家研究发现,高血压患者的饮食中,摄入的钠过多,而钾过少。摄入高钾食物,可以促使体内过多的钠排出,有辅助降压的效果。黑豆含有丰富的钾元素,每100克黑豆含钾量高达1503毫克。高血压患者常吃黑豆,对及时补充体内钾元素很有帮助。
7、本发明富含有小米;
(1)首先小米对消化不好的人群是非常适宜的食物,它不仅可以加快人体的新陈代谢,最重要的是它还可以促进肠道蠕动,从而起到帮助我们消化的功效。
(2)其次小米也是非常养胃的食物,它不仅可以缓解胃痛,缓和胃酸,最主要的是它还可以治疗和预防一些慢性胃病,从而降低肠道疾病的几率。
(3)小米它还有滋阴养血的功效,它不仅适合那些平时贫血的患者服用,最适合那些刚生过孩子的产妇们经常食用,它可以促进产后恢复,可以是产后湿寒的体质得到调理,当然也可以尽快恢复体力。
(4)平时多喝小米汤,多食用一些与小米有关的食物,也可以减低血糖,让体内脂肪得到分解,平衡体内脂肪,从而起到降低血糖的作用,所以小米更加适合高血糖和高血脂的患者,当然也是很好的减肥食谱。
(5)在我们平时的饮食中多喝小米汤也可以起到养阴补虚,润肺补肾的作用,它不仅适合小孩食用,最适合那些肺肾虚弱,和肾脏亏损的患者食用,所以它是非常有营养而且又廉价的食补材料。
(6)最后平时多喝小米粥,也可以起到健脾的功效,他不仅适用于脾气虚弱,运化无力所致的腹胀腹泻,当然还可以治疗和预防食欲不振,身体乏力等等症状。
8、本发明包括白扁豆;
(1)白扁豆的膳用价值;白扁豆,营养价值较高,矿物质和维生素含量比大部分根茎菜和瓜菜都高,味亦鲜嫩可口。据中国科学院卫生研究所编的《食物成分表》:每百克白扁豆含蛋白质2.8g,脂肪0.2g,糖5.4g,热量35kcal,粗纤维1.4g,钙116mg,铁1.5mg,胡萝卜素0.32mg,硫胺酸0.05mg,核黄酸0.07mg,尼克酸0.7mg,抗坏血酸13mg。白扁豆作为滋补佳品,夏暑又是一种清凉饮料。
(2)白扁豆的药用价值;关于白扁豆的文字记载,最早见于南朝齐梁间陶弘景著的《名医别录》。明李时珍著的《本草纲目》说:“取硬壳白扁豆,连皮炒熟,入药”,“硬壳白扁豆,其子充实,白而微黄,其气腥香,其性温平,得乎中和,脾之谷也。人太阴气分,通利三焦,能化清降浊,故专治中宫之病,消暑除湿而解毒也。其软壳及黑鹊色者,其性微凉,但可供食,亦调脾胃。”卫生部药典委员会编的《中国药典》也说:白扁豆“健脾胃,清暑湿。用于脾胃虚弱、暑湿泄泻、白带”。白扁豆其性味甘微温,入脾胃二经,有补脾胃,和中化湿,消暑解毒的功效,主治脾胃虚弱、泄泻、呕吐、暑湿内蕴、脘腹胀痛、赤白带下等病,又能解酒毒。
9、本发明包括淮山药;淮山药作为高营养食品含有大量蛋白质、糖类、B族维生素、维生素C、维生素E、葡萄糖、粗蛋白氨基酸、胆汁碱、尿囊素、及碘、钙、铁、磷等人体不可缺少的无机盐和微量元素等营养成分。中医认为,山药“主伤中补虚,除寒热邪气,补中益气力,长肌肉,久服耳目聪明”。 富滋补健身、养颜美容之功效,是不可多得的健康营养美食。
山药是山中之药、食中之药。不仅可做成保健食品,而且具有调理疾病的药用价值。《本草纲目》指出:山药治诸虚百损、疗五劳七伤、去头面游风、止腰痛、除烦热、补心气不足、开达心孔、多记事、益肾气、健脾胃、止泻痢、润毛皮,生捣贴肿、硬毒能治;《医学衷中参西录》中的玉液汤和滋培汤,以山药配黄芪,可治消渴、虚劳喘逆,经常结合用枸杞子、桑椹子等这些药食同源的中药材做茶泡饮,可补肾强身,增强抵抗力,可以起到较好的保健养生功效。
现代医学研究认为,淮山药有如下作用:
(1)降血压中药六味地黄丸、八味地黄丸、归芍地黄丸等,都是有山药配成的有名方剂,不仅用于治疗肾虚病症,还用于治疗高血压、糖尿病、哮喘、神经衰弱和腰痛等病症。
(2)延缓衰老现代科学证明,山药能使加速有机体衰老的酶活性显著降低。含山药的八味地黄丸,主治产后虚汗不止。保元清降汤、保元寒降汤,可治吐血和鼻出血;寒淋汤和膏淋汤,可治淋虫。山药还可治肺结核、伤寒及妇女病等,这都有利于延年益寿。
(3)抗肿瘤作用山药块茎富含多糖,可刺激和调节人类免疫系统。因此常作增强免疫能力的保健药品使用。山药多糖对环磷酰胺所导致的细胞免疫抑制有对抗作用,能使被抑制的细胞免疫功能部分或全部恢复正常。山药还能加强白细胞的吞噬作用。如,六味地黄丸可治疗慢性肾炎、高血压、糖尿病、神经衰弱等病症。知柏地黄丸可治疗强直性脊椎炎和妇科胎漏、阴痒、经闭等阴虚火旺症。归芍地黄丸可治疗耳痛耳鸣,阴虚自汗等。
(4)可治皮肤病山药中所含的尿囊素具有麻醉镇痛的作用,可促进上皮生长、消炎和抑菌,常用于治疗手足皲裂、鱼鳞病和多种角化性皮肤病。
10、本发明包括莲子;莲子具有清热降火、降血压、促进睡眠、补脾止泻、止带、益肾涩精、养心安神之功效。常用于脾虚泄泻,带下,遗精,心悸失眠。
(1)《本草纲目》:“莲之味甘,气温而性涩,禀清芳之气,得稼穑之味,乃脾之果也。土为元气之母,母气既和,津液相成,神乃自生,久视耐老,以其权舆也。昔人治心肾不交,劳伤白浊,有清心莲子饮;补心肾,益精血,有瑞莲丸,皆得此理。”
(2)《玉楸药解》:“莲子甘平,甚益脾胃,而固涩之性,最宜滑泄之家,遗精、便溏,极有良效。”
(3)《医林纂要》:“去心连皮生嚼,最益人,能除烦、止渴、涩精、和血、止梦遗、调寒热。煮食仅治脾泄、久痢、厚肠胃,而交心肾之功减矣。更去皮,则无涩味,其功止于补脾而已。
11、本发明包括白茯苓;白茯苓的功效如下:
(1)渗湿利水;健脾和胃;宁心安神。用于小便不利、水肿胀满、痰饮咳逆、呕吐、脾虚食少、泄泻、心悸不安、失眠健忘、遗精白浊。
(2)《本草衍义》:白茯苓、茯神,行水之功多,益心脾不可闹也。《用药心法》:白茯苓,淡能利窍,甘以助阳,除湿之圣药也。味甘平补阳,益脾逐水,生津导气。《本经》:主胸胁逆气,忧恚惊邪恐悸,心下结痛,寒热烦满,咳逆,口焦舌干,利小便。《别录》:止消渴,好睡,大腹,淋沥,膈中痰水,水肿淋结。开胸腑,调脏气,伐肾邪,长阴,益气力,保神守中。《药性论》:开胃,止呕逆,善安心神。主肺痿痰雍。治小儿惊痫,心腹胀满,妇人热淋。《日华子本草》:补五劳七伤,安胎,暖腰膝,开心益智,止健忘《伤寒明理论》:渗水缓脾。《医学启源》:除湿,利腰脐间血,和中益气为主。治溺黄或赤而不利。《主治秘诀》云,止泻,除虚热,开腠理,生津液。《药征》:主治悸及肉瞤筋惕,旁治头眩烦躁。
白茯苓的作用如下:
(1)利尿作用。
(2)抗菌作用。
(3)对消化系统的影响:白茯苓对家兔离体肠管有直接松弛作用。
(4)抗肿瘤作用:白茯苓中的主要成分为白茯苓聚糖,含量很高。
(5)白茯苓多糖体对免疫功能的影响:各种白茯苓多糖体在体内均能增强T淋巴细胞的细胞毒性作用。
(6)对血液系统的影响:能使环磷酰胺所致大白鼠白细胞减少加速回升。
(7)对中枢神经系统的影响:白茯苓有镇静作用。
(8)白茯苓可健脾,对那些久病瘦弱、食欲不振或兼有体倦乏力、腹泻的气虚脾弱病人有扶脾益气的作用,而且药性平和。
12、本发明包括薏苡仁;生薏米偏寒凉,利水渗湿最在行,可以去湿除风、清热排脓、除痹止痛,对小便不利、水肿、脚气和风湿疼痛等效果显著。薏米炒黄能缓和药的过偏之性,同时散发的香气,还有理气解郁的作用。
13、本发明包括山楂;山楂的功效如下:
(1)老年人常吃山楂制品能增强食欲,改善睡眠,保持骨骼和血液中钙的恒定,预防动脉粥样硬化,因此山楂被视为“长寿食品”。
(2)山楂含有大量的维生素C与微量元素,能够扩张血管,降低血压,降低血糖,能够改善和促进胆固醇排泄而降低血脂,预防高血脂的发生,山楂能够开胃促进消化,山楂所含有的脂肪酶也能够促进脂肪的消化。
(3)山楂所含有的黄酮类与维生素c、胡萝卜素等物质能够阻断并减少自由基的生成,可增强机体的免疫力,延缓衰老,防癌抗癌。山楂能够活血化瘀,帮助消除瘀血状态,辅助治疗跌打损伤。山楂对子宫有收缩作用,在孕妇临产时有催生效果。
(4)常食山楂能够扩张血管、降低血糖、降低血压,防治心血管疾病和老年性心脏病。利用山楂果实治疗疾病,在中国已有悠久的历史。《唐本草》记:汁服用止水痢;《本草纲目》记:山楂化饮食,消肉滞等。凡脾胃虚弱,食物不消化,胸腹酸刺胀闷者,于膳后Ⅱ爵两三枚绝佳。中医认为,山楂更具有生津止渴,活血化瘀等功能。而且近代药物理化研究发现山楂的药用价值渗透到血液血脂领域更为明显。
14、本发明包括海带;海带是一种营养价值很高的蔬菜,同时具有一定的药用价值。含有丰富的碘等矿物质元素。海带含热量低、蛋白质含量中等、矿物质丰富,研究发现,海带具有降血脂、降血糖、调节免疫、抗凝血、抗肿瘤、排铅解毒和抗氧化等多种生物功能。
海带的主要功效如下:
(1)抗辐射;海带的提取物海带多糖因抑制免疫细胞凋亡而具有抗辐射作用。
(2)瘦身功效:
海带含有大量的营养,它含有丰富的钾、碘等矿物质,这种物质对人体有很大的营养,海带其实还可以瘦身。
海带含有大量的碘,它具有“碱性食物之冠的美称”,前几年有地方称很多人都患有粗脖子,是因为一直食用大盐,没用碘盐的原因。其实粗脖子是由于甲状腺机能减退引起的,碘可以促使甲状腺的机能提升,对于热量消耗及身体的新陈代谢相当有帮助,进而达到减重及控制体重的目的。
钾也是海带营养的一大重点,许多人都把钾忽略掉,忽略钾,就忽略了三分之一的营养,钾是一种可以消除身体浮肉的矿物质,它可以帮助平衡身体内的钠,如果身体内的钾太少,造成身体内的钠钾平衡失调多余的钠会把水分流住,造成细胞水肿,使得体重下不来浮肉更明显。但是如果钾离子身体摄取量足够,钠离子就不会把多余的水分留住。所以钾离子可帮助身体多余水分的代谢消除水肿改善浮肉修饰曲线。
海带中还含有大量的不饱合脂肪酸及食物纤维,它可以迅速清除血管管壁上多余的胆固醇,并且帮助胃液进行分泌,达到消化的目的,对于肠胃蠕动有很大帮助。
海带热量低且充满胶质、矿物质。海带中还富含可溶性纤维,比一般纤维更容易消化吸收,帮助身体顺畅排便。而且我们可以把海带作为宵夜或点心,因为海带不会长胖。
(3)美发作用;一个人的头发之枯荣,在一定程度上反映出人体的营养状况。除去生理性衰老引起头发的变化之外,一般认为头发浓密、乌黑、有光泽,说明营养状况良好;反之,头发稀疏、枯黄、无光泽,且大量脱落、折断,则是营养欠佳的表现。与头发有关的营养因素,除去能量、蛋白质、维生素外,还有一个不容忽视的因素——微量元素。
黄头发的产生主要是由于酸毒症的存在,而白头发的产生主要是由于酸毒症的发展所致。人的体力和精力过于疲劳,吃甜食太多,蛋白质缺乏,尤其是碘元素的缺少,都会助长自身发生酸毒症。
众所周知的海带,不仅营养价值颇高,除了含有多种维生素,纤维素和矿物质外,而且,还是防治甲状腺肿的良药。海带中的碘极为丰富,此元素为体内合成甲状腺素的主要原料。而头发的光泽就是由于体内甲状腺素养发挥作用而形成的。“头发质素”和所含有的角质成分,要从含硫的蛋白质中吸取,而蛋白质又是使头发产生光泽的重要物质。海带中除含有碘、钙、硫之外,还含有铁、钠、镁、钾、钴、磷、甘露醇和维生素B1、B2、C等多种物质。这些营养物对美发皆大有裨益。因此,常吃海带,对头发的生长、润泽、乌黑、光亮都具有特殊的功效。
(4)延缓衰老;海带富含钙元素与碘元素,有助于甲状腺素合成,这两种元素搭配,不仅能美容,还有延缓衰老的作用。
(5)健脑补脑;海带中含有牛磺酸,他对儿童大脑发育和成长能起到十分重要的作用。海带表面褐色表层里还含有一种促进儿童发育的谷氨酸,其含量高出肝油30倍,可健脑补脑,有助于儿童健康地发育成长。
(6)肠胃“清道夫”;海带中含有丰富的纤维素,能够及时地清楚肠道内废物和毒素,因此,可以有效地防止直肠癌和便秘的发生。
15、本发明包括黑木耳;黑木耳的营养成分,据现代科学分析,每100g干品中含蛋白质10.6g,脂肪0.2g,碳水化合物65g,粗纤维7g,钙375mg,磷201mg,铁185mg,此外还含有维生素B10-15mg,维生素B20-55mg,烟酸2.7mg;而且有增加食欲和滋补强身的作用。黑木耳具有一定吸附能力,对人体有清涤胃肠和消化纤维素的作用。
黑木耳还可作药用。历代医学家对于黑木耳的药效都有详细的记载,如明代李时珍在《本草纲目》中记载:"木耳生于朽木之上,性甘平,主治益气不饥,轻身强志,并有治疗痔疮、血痢下血等作用。"我国医学历来认为黑木耳有滋润强壮,清肺益气,补血活血,镇静止痛等功效。是中医用来治疗腰腿疼痛,手足抽筋麻木,痔疮出血和产后虚弱等病症常用的配方药物。据国外报道,黑木耳能减低血液凝块,缓和冠状动脉粥样硬化,对预防和治疗冠心病有特殊的效益。黑木耳所含的多糖类物质,具有一定抗肿瘤作用,据报道对小白鼠肉瘤180的抑制率为42.6%。我国民间也有用黑木耳加水煎服,来治疗妇女子宫颈癌和阴道癌。黑木耳不但肉质细腻,脆滑爽口而且营养丰富,含有蛋白质、脂肪、碳水化合物和多种维生素与无机盐,黑木耳所含的营养物质,有的明显高于其它食物,它的蛋白质的含量相当于肉类,它的维生素B2含量超过米、面、蔬菜和肉类,铁的含量比肉类高100倍,钙的含量是肉类的30-70倍,它还含有磷和硫等构成人体细胞原生质的主要成份。由于黑木耳所含各种营养完善而丰富,被誉为"素中之荤"。
研究发现,黑木耳具有化解体内结石的功效。这主要是因为黑木耳中所含有的发酵素和植物碱,能够有效的促进消化道和泌尿道内各种腺体的分泌,并催化体内结石、润滑管道、促使结石排出。因此,专家建议,对于患有体内结石的病人,不妨每天有意识地吃上1~2次的黑木耳。这样,不但可以缓解病人的疼痛、恶心及呕吐等症状,甚至还可以使人体内的许多结石自然消失。
此外,黑木耳中所含有的多种矿物质元素还能使体内的各种结石产生化学反应,剥脱,瓦解,不断脱屑缩小,然后再经管道排出。另外,黑木耳中还含有较多量的具有清洁血液和解毒功效的生物化学物质,有利于人体健康。黑木耳性味功能:甘、平,无毒。入胃、肝、大肠经,能补气血, 血止血,润肺益胃,润燥利肠,舒筋活络,轻身强志。治疗血虚气亏、四肢抽搦、肺虚咳嗽、咯血、吐血、衄血、产后虚弱、白带过多、崩漏、血痢、肠风痔血、便秘和跌打损伤等症状。
黑木耳的药理作用如下:
(1)降血糖作用;木耳多糖对四氧嘧啶糖尿病小鼠高血糖有防治作用,使实验小鼠葡萄糖耐受量及耐受量曲线得到明显改善,还能减少糖尿病小鼠饮水量。
(2)降血脂作用;木耳多糖能明显降低高血脂症大鼠血清游离胆固醇、胆固醇脂、三酰甘油、 9—脂蛋白含量,降低高胆固醇引起的小鼠高胆固醇血症的形成。
(3)抑制血小板聚集;腺苷及相关的几种水溶性低分子物,能明显延长凝血酶原时间抑制血小板聚集的浓度,证明腺苷是一种强效血小板聚集抑制剂。它可被小肠完整无损地吸收,但该活性物不影响[14C]花生四烯酸合成凝血恶烷,显示该物质不抑制血小板环氧化酶的功能。
(4)抗血栓形成;木耳多糖可明显延长家兔特异性血栓及纤维蛋白血栓的形成时间,缩短血栓长度,减轻血栓湿重和干重,减少血小板数,降低血小板粘附率和血液粘度,并可明显缩短豚鼠优球蛋白溶解时间,降低血桨纤维蛋白原含量,升高纤溶酶活性,具有明显抗血栓形成的作用。
(5)提高机体免疫功能;木耳多糖对机体免疫功能有明显促进作用,包括增加脾指数,半倍溶血值和玫瑰花结形成率,促进巨噬细胞吞噬功能和淋巴细胞转化率,增加机体细胞免疫和体液免疫功能,具有显著及抗肿瘤活性。
(6)抗衰老作用;木耳多糖可使小鼠心肌血组织褐指质含量下降,使脑和肝中超氧化物歧化酶活力增加,对小鼠离体脑B型单氨氧化酶(HA0—B)活性起抑制作用,提示木耳多糖具有抗衰老活性。
(7)对组织损伤有保护作用;木耳多糖有明显增强核酸和蛋白质代谢的作用、能增加肝微粒体含量,促进血清蛋白质的生物合成,增强机体抗病能力,对机体损伤有保护作用。
(8)改善心肌缺氧;木耳多糖能延长小鼠常压耐缺氧实验的生存时间,提高生存率,提示木耳多糖对改善缺血心肌对氧的供求失调有一定作用。
(9)抗溃疡作用;木耳多糖能明显抑制大鼠应激型溃疡的形成,促进醋酸型胃溃疡的愈合。
(10)抗放射作用;木耳多糖抗放射作用优于银耳多糖,能对抗由环磷酰胺引起的白细胞降低。
(11)抗溃疡作用;黑木耳中所含的蛋白质、脂肪、糖类,不仅是人体必需的营养成分,也是美容的物质基础。其胡萝卜素进入人体后,转变成维生素A,有润泽皮肤毛发的作用。卵磷脂在体内可使体内脂肪呈液质状态,有利于脂肪在体内完全消耗,带动体内脂肪运动,使脂肪分布合理,形体匀称。纤维素促进肠蠕动,促进脂肪排泄,有利于减肥。
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对本发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。
Claims (3)
1.一种健脾胃、抗动脉硬化、降三高、补钙养颜的面粉,其特征在于,以重量配比计包括:人参50~100份、燕麦50~100份、玉米50~100份、苦荞麦50~100份、葛根50~100份、黑豆50~100份、小米50~100份、白扁豆50~100份、淮山药50~100份、莲子50~100份、白茯苓50~100份、薏苡仁50~100份、芡实50~100份、陈皮50~100份、山楂50~100份、莱菔子50~100份、海带50~100份、红曲50~100份、黑木耳50~100份、鸡内金50~100份、虾米50~100份、海藻50~100份、木香50~100份、砂仁50~100份。
2.根据权利要求1所述的健脾胃、抗动脉硬化、降三高、补钙养颜的面粉,其特征在
于,以重量配比计包括:人参50份、燕麦50份、玉米50份、苦荞麦50份、葛根50份、黑豆50份、小米50份、白扁豆50份、淮山药50份、莲子50份、白茯苓50份、薏苡仁50份、芡实50份、陈皮50份、山楂100份、莱菔子50份、海带100份、红曲50份、黑木耳50份、鸡内金50份、虾米50份、海藻50份、木香50份、砂仁50份。
3.根据权利要求1所述的健脾胃、抗动脉硬化、降三高、补钙养颜的面粉,其特征在于,以重量配比计包括:人参50份、燕麦80份、玉米80份、苦荞麦80份、葛根80份、黑豆80份、小米80份、白扁豆80份、淮山药80份、莲子80份、白茯苓80份、薏苡仁80份、芡实80份、陈皮100份、山楂100份、莱菔子50份、海带100份、红曲50份、黑木耳50份、鸡内金50份、虾米50份、海藻50份、木香50份、砂仁50份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810408590.XA CN109998021A (zh) | 2018-05-02 | 2018-05-02 | 健脾胃、抗动脉硬化、降三高、补钙养颜的面粉 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810408590.XA CN109998021A (zh) | 2018-05-02 | 2018-05-02 | 健脾胃、抗动脉硬化、降三高、补钙养颜的面粉 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109998021A true CN109998021A (zh) | 2019-07-12 |
Family
ID=67164807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810408590.XA Pending CN109998021A (zh) | 2018-05-02 | 2018-05-02 | 健脾胃、抗动脉硬化、降三高、补钙养颜的面粉 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109998021A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116035201A (zh) * | 2023-02-03 | 2023-05-02 | 赵文欣 | 能调节代谢功能食疗产品 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101606694A (zh) * | 2008-06-19 | 2009-12-23 | 刘泳宏 | 一种天然五色降脂降糖降压粥及制作方法 |
CN102138671A (zh) * | 2010-02-02 | 2011-08-03 | 孔赟荣 | 一种人参八珍保健糕的配方和制成方法 |
CN103609952A (zh) * | 2013-11-28 | 2014-03-05 | 江西同乐堂医药生物科技有限公司 | 一种健脾营养配方谷粉及其制备方法 |
CN103621984A (zh) * | 2012-08-27 | 2014-03-12 | 浙江劲膳美生物科技有限公司 | 降压降脂食疗配餐或代餐品 |
CN104738628A (zh) * | 2015-04-10 | 2015-07-01 | 吴春生 | 一种健脾养胃粉及其制备方法 |
CN105011158A (zh) * | 2015-06-30 | 2015-11-04 | 东莞市健来福实业投资有限公司 | 一种健脾胃的保健品及其制备方法 |
CN106235317A (zh) * | 2016-08-19 | 2016-12-21 | 林力 | 健脾养胃五谷杂粮食疗粉 |
CN107375819A (zh) * | 2017-09-01 | 2017-11-24 | 张蓓 | 一种健脾消食的中药 |
-
2018
- 2018-05-02 CN CN201810408590.XA patent/CN109998021A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101606694A (zh) * | 2008-06-19 | 2009-12-23 | 刘泳宏 | 一种天然五色降脂降糖降压粥及制作方法 |
CN102138671A (zh) * | 2010-02-02 | 2011-08-03 | 孔赟荣 | 一种人参八珍保健糕的配方和制成方法 |
CN103621984A (zh) * | 2012-08-27 | 2014-03-12 | 浙江劲膳美生物科技有限公司 | 降压降脂食疗配餐或代餐品 |
CN103609952A (zh) * | 2013-11-28 | 2014-03-05 | 江西同乐堂医药生物科技有限公司 | 一种健脾营养配方谷粉及其制备方法 |
CN104738628A (zh) * | 2015-04-10 | 2015-07-01 | 吴春生 | 一种健脾养胃粉及其制备方法 |
CN105011158A (zh) * | 2015-06-30 | 2015-11-04 | 东莞市健来福实业投资有限公司 | 一种健脾胃的保健品及其制备方法 |
CN106235317A (zh) * | 2016-08-19 | 2016-12-21 | 林力 | 健脾养胃五谷杂粮食疗粉 |
CN107375819A (zh) * | 2017-09-01 | 2017-11-24 | 张蓓 | 一种健脾消食的中药 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116035201A (zh) * | 2023-02-03 | 2023-05-02 | 赵文欣 | 能调节代谢功能食疗产品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
CN106722963A (zh) | 一种素食餐 | |
CN108887564A (zh) | 一种硒蛋白杂粮粉配方及其制备方法 | |
CN104489516A (zh) | 提高肿瘤患者术后免疫功能的养生粥及制法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN103461585B (zh) | 补气养生中药茶 | |
CN105232911B (zh) | 一种中药组合物 | |
CN104738640A (zh) | 一种高丽红参膳食纤维大豆蛋白膨化粉的制备方法 | |
CN104323391B (zh) | 一种植物保健固体饮料及其制备方法 | |
CN103704568B (zh) | 临床膳食食品 | |
CN108497277A (zh) | 复合果蔬抗癌营养餐配方 | |
CN104905061A (zh) | 一种牛配合饲料及其制备方法 | |
CN101248881B (zh) | 一种具有改善女性更年期健康作用的营养食品 | |
KR20080090808A (ko) | 피부미용을 위한 건강보조식품의 조성물 | |
CN110638038A (zh) | 一种用于控制高血糖的医学配方营养代餐粉及其制备方法 | |
CN103751762B (zh) | 一种促进肌肤细胞重组并能延缓衰老的产品 | |
CN109998021A (zh) | 健脾胃、抗动脉硬化、降三高、补钙养颜的面粉 | |
CN109224021A (zh) | 治疗糖尿病、降血压、降血脂的保健养生茶及制备方法 | |
CN104605372A (zh) | 一种基于恶性肿瘤放疗患者的营养药膳及制备方法 | |
CN108013459A (zh) | 一种具有减肥美容功能的保健食品及其制备方法 | |
CN105105127A (zh) | 一种红果舒心粉多功能保健食品 | |
CN109965199A (zh) | 一种药食同源营养代餐粉及其制备方法 | |
CN110089754A (zh) | 肝胆保健品 | |
CN109289017A (zh) | 用于清理血管和血液的组合物及制备方法 | |
CN108669140A (zh) | 具有高纤维低升糖的全营养饼干及其加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190712 |